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Background: An association between metabolic syndrome (MeS) and osteoarthritis (OA) has been
reported in recent years; however, conﬂicting ﬁndings have been reported regarding this matter.
Inhere we evaluated the relationship between different components of MeS and OA in a Fasa
osteoarthritis registry (FOAS).
Methods: The registry includes all OA cases who referred to Fasa hospital (Iran) since 2013. Overall, 131
patients with OA with a Kellgren & Lawrence (K&L) score >1 and 261 controls were compared.
Results: Overall, 82.4% of individuals in the OA group and 40.8% of participants in the control group had
MeS (P < 0.001). Patients with OA had a 6.8 (95% CI: 4.1–11.4) higher chance of acquiring MeS. After
adjusting for sex, age, and BMI, odds’ ratio (OR) for acquiring MeS in OA group increased to 10.9 (95% CI:
5.5–21.8). Among MeS criteria’s, high waist circumference (WC) has strongest correlation for acquiring
OA (OR = 27.535, 95% CI: 6.003–126.306).
Conclusion: Our ﬁndings revealed that metabolic markers are strongly associated with OA and the
addition of each component of the MeS, signiﬁcantly increases the risk of developing OA, therefore
control of metabolic factors and appropriate screening must be considered in health policy making and
prevention programs.
© 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Diabetes & Metabolic Syndrome: Clinical Research &
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journal homepa ge: www.elsev ier .com/locate /dsx1. Introduction
Osteoarthritis (OA) is one of the most disabling diseases
afﬂicting the elderly population. It has been estimated that,
approximately 25% of people over the age of 55 years old,
experience permanent pain and roughly 10%, experience debili-
tating pain in their knees [1]. Based on disability adjusted life years
(DALY) an annual estimated 2,118,000 years of human lives are lost
due to the disease [2]. OA mostly targets middle aged people (45–
65 years) [3] and patients usually go through a rapid course of* Corresponding author at: Noncommunicable Diseases Research Center, Fasa
University of Medical Sciences, Fasa, Iran.
E-mail addresses: r_homayounfar@yahoo.com, homayounfar@sbmu.ac.ir
(R. Homayounfar).
1 These two authors have equal contribution to this work.
http://dx.doi.org/10.1016/j.dsx.2017.07.002
1871-4021/© 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.
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and metabolic disorders are among factors believed to play a role in
OA pathogenesis [5,6], however etiology of the disease is not fully
recognized.
The link between metabolic disorders and OA has been a subject
of interest in recent years to the extent that the idea of metabolic
OA has been proposed [7]. Most studies evaluating the connection
between metabolic markers and OA, have focused their attention
on OA of the hand, since it is least affected by the imposed weight
load on joints. However, distinct characteristics of different joints
affect their susceptibility to diseases [8].
Metabolic syndrome (MeS) is characterized by insulin resis-
tance, dyslipidemia, hypertension and abdominal obesity which
can lead to diseases such as type II diabetes and cardiovascular
diseases [9–11]. Even though the deﬁnition of MeS is highly
variable for different population [7,12], studies show that about
59% of OA patients have MeS [4,13].etabolic syndrome and osteoarthritis: The Fasa Osteoarthritis Study,
7.07.002
Table 1
Patients’ baseline characteristics.
Variables Control (n = 262) Osteoarthritis (n = 131) p-value
Age  yrs 55.49  9.12 52.86  8.77 0.007
Waist  cm 86.89  4.76 91.57  4.87 <0.001
BMI  kg/m2 25.97  2.38 28.24  2.19 <0.001
FBS  mg/dl 82.91  21.78 98.34  18.45 <0.001
TG  mg/dl 137.10  38.17 178.37  42.55 <0.001
Chol  mg/dl 151.13  38.90 196.91  43.07 <0.001
HDL  mg/dl 58.20  11.22 54.52  11.02 0.002
LDL  mg/dl 84.99  24.02 105.17  22.83 <0.001
Systolic BP  mmHg 13.34  1.21 14.42  1.40 <0.001
Diastolic BP  mmHg 8.71  1.03 9.30  1.05 <0.001
WOMAC score 5.50  2.80 15.11  3.25 <0.001
K&L 0 2.93  0.59 <0.001
FBS: fasting blood sugar; TG: triglyceride; Chol: cholesterol; HDL: high density
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regarding the relationship between OA and MeS. These studies
have mostly failed to ﬁnd a signiﬁcant connection between MeS
and the risk of OA, after adjusting for variables such as weight or
body mass index (BMI). Inhere we evaluated the relationship
between different components of MeS and OA in a cohort registry
entitled the Fasa Osteoarthritis Study (FOAS).
2. Patients and methods
2.1. Study protocol
This study is part of an OA registry afﬁliated to Fasa University of
Medical Sciences termed the Fasa osteoarthritis study (FOAS). The
registry includes all OA cases who referred to Fasa hospital (Iran)
since 2013. Currently the database includes 131 registered patients
with OA.
Diagnosis of OA was based on having a Kellgren & Lawrence
(K&L) score >1 [14]. We considered a control group of 262
individuals from those referring to the orthopedic clinic of the
hospital without complaints of pain and/or stiffness in their knee
or hip. The inclusion criteria for the control group was lack of
radiographic complication caused by OA in the knee and hip (K&L
score = 0).
The case and control groups were matched according to gender.
Blood samples were taken from all patients in one day at the
central laboratory of the University.
2.2. Measurements
For the anthropometric measurements participants stood bare
footed with light clothing. Waist circumference (WC) was
considered at midpoint of the inferior border of the lowest ribs
to the anterior superior iliac spine, after the participant had a
normal expiration, using an inelastic tape.
For the anthropometry calculations weight was measured to
the nearest 0.1 kg using a digital scale (Seca 767, Japan) and height
was also measured to the nearest 0.1 cm using a stadiometer (Seca
767, Japan). Anthropometric index included BMI, which was
considered weight divided by the square of height (kg/m2).
Other measurements included blood pressure (BP), which was
done using a sphygmomanometer (Erka Perfect Aneroid,
Germany). For evaluating BP, participants ﬁrst rested for ten
minutes, after which with an interval of ﬁve minutes, three
consecutive BP’s were measured from participants’ right arm and a
mean was calculated and considered the ﬁnal BP.
Blood work included triglyceride (TG), cholesterol (Cho), low
density lipoprotein cholesterol (LDL-c), high density lipoprotein
cholesterol (HDL-c), and fasting blood sugar (FBS), which were all
obtained from venous blood samples.
Laboratory testing of FBS was done using a glucose oxidize test
(intra- and inter-assay coefﬁcients of variation less than 2.1 and
2.6, respectively). For lipid proﬁle an enzymatic approach
(Parsazmoon Inc., Tehran, Iran), was used. We used the Friedewald
formula to calculate LDL-c levels [15].
The National Cholesterol Education Program’s Adult Treatment
Panel (ATP) III revised guidelines were used for the diagnosis of
MeS. Those participants who had three or more of the following
criteria were considered having MeS: systolic BP >130 mmHg and/
or diastolic BP >85 mmHg, TG 150 mg/dl, HDL-c <40 mg/dl for
male and <50 mg/dl for females, FBS >100 and WC >88 cm for
women or WC >102 cm for men [16].Please cite this article in press as: A. Askari, et al., Relationship between m
Diab Met Syndr: Clin Res Rev (2017), http://dx.doi.org/10.1016/j.dsx.201For evaluating pain, the Western Ontario and McMaster
universities arthritis index score (WOMAC) was also measured
[17].
2.3. Ethical consideration
The study protocol followed the principals of the “Declaration
of Helsinki”. The Institutional Review Board (IRB) of Fasa University
of Medical Sciences approved the study. Written and informed
consents were obtained from all the participating in the study.
2.4. Statistical analysis
Data was analyzed using SPSS1 for windows1, version 22 (SPSS
Inc., Chicago, IL, USA).
Comparison of means of normally distributed variables
between the OA and the control group was done using the
independent t-test and the chi-square test for quantitative and
qualitative variables, respectively. The multiple logistic regression
model was used to evaluate the effect of MeS on OA. In our
multivariate analysis, we added each of the components of the MeS
in a separate manner to evaluate the independent effects of each
component of MeS on OA, furthermore the model was adjusted for
sex, age and BMI for each of the analysis.
The linear regression model was used to determine WOMAC
score correlates. We also reported the Wald statistics to evaluate
the power of association of each variable with OA.
All data are presented as means and standard deviations (SD) or
percentage and frequency, where appropriate. Our statistical
inference was based on a 95% conﬁdence interval (CI) and a
signiﬁcance threshold of 5%.
3. Results
Baseline characteristics of patients are displayed in Table 1.
Hypertension, abnormal FBS, TG, and HDL (in the context of the
deﬁnition of MeS) were signiﬁcantly higher among (96.2%, 20.6%,
75.6%, and 26.7%, respectively) individuals with OA in comparison
to participants in the control group (81.3%, 12.6%, 37%, and 18.7%,
respectively) (p < 0.05).
Overall, 82.4% of individuals in the OA group and 40.8% of
participants in the control group had MeS (P < 0.001) (Table 2).
In our univariate analysis patients with OA showed a 6.8 (95%
CI: 4.1–11.4) higher chance of acquiring MeS in comparison to
those in the control group. After adjusting for sex, age, and BMI,
odds’ ratio (OR) for acquiring MeS in patients with OA in
comparison to participants in the control group increased to
10.9 (95% CI: 5.5–21.8).lipoprotein; LDL: low density lipoprotein; WOMAC: Western Ontario and McMaster
universities arthritis index; K&L: Kellgren & Lawrence.
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Table 2
Comparison of osteoarthritis and control groups.
Variables Control (n = 262) Osteoarthritis (n = 131) p-value
Sex
Male 48 (18.3) 24 (18.3) 1.000
Female 214 (81.7) 107 (81.7)
HDL  mg/dl
Normal 213 (81.3) 96 (73.3) 0.068
Abnormal 49 (18.7) 35 (26.7)
WC  cm
Normal 46 (17.6) 5 (3.8) <0.001
Abnormal 216 (82.4) 126 (96.2)
HTN  mmHg
Normal 49 (18.7) 5 (3.8) <0.001
Abnormal 213 (81.3) 126 (96.2)
FBS  mg/dl
Normal 229 (87.4) 104 (79.4) 0.037
Abnormal 33 (12.6) 27 (20.6)
TG  mg/dl
Normal 165 (63.0) 32 (24.4) <0.001
Abnormal 97 (37.0) 99 (75.6)
MeS
No 155 (59.2) 23 (17.6) <0.001
Yes 107 (40.8) 108 (82.4)
MeS number of components
0 4 (1.5) 0 (0.0)
1 44 (16.8) 1 (0.8)
2 107 (40.8) 22 (16.8) <0.001
3 79 (30.2) 67 (51.1)
4 27 (10.3) 38 (29.0)
5 1 (0.4) 3 (2.3)
WC: waist circumference; HTN: hypertension; FBS: fasting blood sugar; TG: triglyceride; MeS: metabolic syndrome.
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adding each of the components of MeS, OR for acquiring OA
increases subsequently.
When evaluating the ﬁve component of MeS separately, high
TG, high WC, low HDL, and abnormal FBS (in the context of the
deﬁnition of MeS) were correlated with MeS (p < 0.05). Among
these factors, high TG had the strongest correlation with OA (WaldTable 3
Multivariate analysis for evaluating the relationship between osteoarthritis and metab
Variables OR 95% Conﬁ
No MeS (0 to 2 factors) 
Unadjusted model of MeS 6.802 4.072–11.
Adjusted model of MeS 10.945 5.496–21
Female sex 1.780 0.735–4.3
Age 0.868 0.830–0.9
BMI 1.972 1.686–2.3
MeS with 3 components 8.444 4.112–17.
MeS with 4 components 20.189 8.277–49
MeS with 5 components 31.465 2.708–36
Female sex 1.772 0.727–4.3
Age 0.864 0.826–0.9
BMI 2.003 1.705–2.3
MeS components
TGa 6.028 3.228–11.
Waistb 27.535 6.003–12
HDLc 2.613 1.292–5.2
FBSd 2.393 1.086–5.2
HTNe 3.325 0.986–11.
Female sexf 1.052 0.356–3.1
Age 0.859 0.820–0.9
BMI 2.016 1.701–2.3
MeS: metabolic syndrome; BMI: body mass index; TG: triglyceride; HDL: high density
a TG was considered as >150 mg/dL.
b Waist was considered as >94 for males and >80 for female.
c HDL was considered as <40 for males and <50 for females.
d FBS was considered as >110 mg/dl.
e Hypertension was considered as >130 mmHg for systolic blood pressure or >85 mm
f Sex, age and BMI were adjusted for in all the analysis.
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Diab Met Syndr: Clin Res Rev (2017), http://dx.doi.org/10.1016/j.dsx.201statistics = 31.8, OR = 6.02, 95% CI: 3.228–11.255), furthermore high
WC was another strong correlate for acquiring OA (Wald
statistics = 18.2, OR = 27.535, 95% CI: 6.003–126.306). Hypertension
did not show a statistically signiﬁcant correlation with OA (Wald
statistic = 3.75, OR = 3.32, 95% CI: 0.986–11.21) (Table 3).olic syndrome components in adjusted and non-adjusted models.
dence interval Wald statistics p-value
50.495 <0.001
363 53.634 <0.001
.796 46.349 <0.001
11 1.630 0.202
07 39.232 <0.001
08 71.858 <0.001
340 33.769 <0.001
.244 43.636 <0.001
5.596 7.596 0.006
20 1.581 0.209
04 40.477 <0.001
54 71.510 <0.001
255 31.798 <0.001
6.306 18.199 <0.001
86 7.138 0.008
73 4.689 0.030
218 3.750 0.053
11 0.008 0.927
00 40.436 <0.001
90 65.510 <0.001
 lipoprotein; FBD: fasting blood sugar; HTN: hypertension.
Hg for diastolic blood pressure.
etabolic syndrome and osteoarthritis: The Fasa Osteoarthritis Study,
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Table 4
Linear regression analysis for evaluating the relationship between WOMAC score
and different variables.
Variables Beta 95% conﬁdence interval P-value R2 of model
Constant 6.57 3.188–9.953 <0.001 0.704
MeS 0.371 1.063 to 0.321 0.292
OA 9.894 9.065–10.722 <0.001
Sex 0.197 1.033 to 0.638 0.643
Age 0.003 0.038 to 0.045 0.872
BMI 0.039 0.192 to 0.114 0.620
MeS: metabolic syndrome; OA: osteoarthritis; BMI: body mass index.
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was not correlated with WOMAC score after adjusting for sex, age
and BMI (P = 0.292) (Table 4).
4. Discussion
In this study, we investigated the relationship between MeS and
OA. Our results showed that the prevalence of MeS in OA patients
was higher than those in the control group. When we adjusted for
age, sex and BMI, the correlation between MeS and OA increased
(from 6.8 to 10.94). Our study showed that by an increase in each of
the components of MeS, the risk of acquiring OA rises signiﬁcantly
(patients who have all ﬁve components of MeS and those who have
4 components of the MeS are 31 times and 20 times more likely to
develop OA than patients who do not have MeS). To the best of the
authors’ knowledge, this is the only study that has linked MeS by
each of its components to the risk of developing OA.
The work by Puenpatom et al. [4] can be considered among the
very ﬁrst studies that pointed to the relationship between MeS and
OA. Utilizing the results of a larger study termed the “NHANES III”
study, they found that 59% of the population with OA had MeS,
compared to only 23% of the population who did not have OA.
According to their study, all complications associated with MeS
including: high BP (75% vs. 38%), abdominal obesity (63% vs. 38%),
hyperglycemia (30% vs. 13%), high triglycerides (47% vs. 32%), and
high LDL (44% vs. 38%), had higher frequency among patients with
OA in comparison to an apparently healthy group. They also
showed that the relationship between MeS and OA is stronger at
younger ages and weakens as patients grow older.
Marksabcdef et al. [18] studied 1000 patients with hip OA to
evaluate accompanying diseases. They found that more than 55% of
patients had at least one comorbidity such as hypertension or
cardiovascular disease.
In a cross-sectional study in 2013, Morovic-Vergles et al. [19],
found that among 352 patients with OA, 60% had hypertension
after adjusting for age and BMI.
Schett et al. [20], using data from the “Bruneck Study”, found
that arthroplasty rate was 17.7 (range: 9.4–30.2) in patients with
diabetes type II per 1000 patient-years. They concluded that
diabetes is an independent risk factor for arthroplasty, with a
hazard ratio of 2.1 (range: 1.1–3.8), after adjusting for age, sex, BMI
and prior joint replacements.
A study carried out on 100 diabetic and 102 non-diabetic
individuals by Nieves-Plaza et al. [21] found that the incidence of
OA in diabetics was 49%, while the incidence in non-diabetics was
26.5% (p < 0.01). Multivariate analysis showed that diabetic
patients have an OR of 2.18 for acquiring OA (95% CI: 1.12–4.24)
compared to non-diabetics.
Unfortunately, the majority of studies that investigated the
relationship between MeS and OA, although successful at ﬁnding a
relationship in their early stages of analysis, were unable to ﬁnd a
signiﬁcant link between the two, after adjusting for BMI. Based on
the “Korean National Health and Nutrition Examination Survey”,Please cite this article in press as: A. Askari, et al., Relationship between m
Diab Met Syndr: Clin Res Rev (2017), http://dx.doi.org/10.1016/j.dsx.201Han et al. [22] initially found a positive and signiﬁcant relationship
between MeS and OA in women (OR = 1.798, 95% CI: 1.392–2.322).
However, after adjusting for confounders such as age, alcohol
consumption, and smoking status, they found that only WC was
positively associated with increased risk of knee OA (OR = 1.117, 95%
CI: 0.805–1.550). The study found no relationship between MeS
and OA in men.
In a cohort study by Engstrom et al. [23] they found that MeS
was associated with increased incidence of OA of the knee. The
relationship continued to exist even after adjusting for sex, age,
smoking, and physical activity. However, the positive correlation
was non-exiting after adjusting for BMI. One of the interesting
ﬁndings of this study was that they documented a different
response to MeS based on the involved joints (hip or knee).
The relationship between diabetes and OA is also a subject of
controversy. Early studies did not ﬁnd any association between
these two diseases, in addition the results of the “First National
Health and Nutrition Examination Survey” also found a lack of
association between the two conditions [24]. This ﬁnding was also
conﬁrmed by other studies [25,26]. In general, studies found that
other than BMI and obesity, no other metabolic variable relates to
OA.
In a cohort study with a population of 6197, Garessus et al. [27]
calculated an adjusted OR of 1.18 per one unit increase in blood
sugar (serum glucose). They found no signiﬁcant relationship
between metabolic markers of blood sugar including glucose
levels, insulin, HbA1C or homeostatic model assessment-IR, and
the occurrence of OA. It seems that since the study examined
patients with normal BMI (average BMI of the population was 26
and ranged from 22 to 30), they were not been able to show a
strong and signiﬁcant correlation between the two variables.
In our study, BP was not signiﬁcantly associated with OA
(OR = 3.325, 95% CI: 0.986–11.218). It seems that even after
adjusting for variables such as sex, age, and BMI, BP would still
have an insigniﬁcant association with OA compared to other
components of the MeS.
Among MeS components, TG and WC had the strongest
correlation with OA. The most interesting ﬁnding in our study,
which we showed for the ﬁrst time, was that perhaps TG (as part of
the MeS) may play a crucial role in the pathogenesis of OA and has
the strongest association with OA, even after adjusting for other
variables. Therefore, we recommend further studies evaluate the
role of TG in the pathogenesis of OA.
We also found that WC, independent from BMI, which has been
mentioned as a major risk factor by most studies, is strongly
correlated with OA. Aside to the increased mechanical load
imposed on the joints due to high BMI, abdominal obesity seems to
independently take part in OA pathogenesis due its unique role
with systematic inﬂammatory mediators and adipokines in the
body [28].
In line with existing studies [20,29], our study showed that
metabolic markers can add to the risk of OA. The addition of each
component of the MeS, signiﬁcantly increases the risk of
developing OA. However, several research studies revealed no
association between the prevalence of OA and metabolic markers.
Numerous factors may have clouded the relationship between OA
and MeS, including discrepancies associated with study popula-
tion, race, sample size, life style, and diet. Moreover, different
diagnostic methods and procedures to evaluate OA like radiologi-
cal ﬁndings, self-assessment or symptom revision, may have also
played a role in this matter. Even the criteria for diagnosis of MeS
were different among studies [7,30].
The relationship between the two conditions has only been
reported signiﬁcant, when studies considered MeS with all of its
criteria [29,31,32].etabolic syndrome and osteoarthritis: The Fasa Osteoarthritis Study,
7.07.002
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load on the joints, has long been recognized [13]. However, we
found that MeS components each play an independent role in OA
pathogenesis.
We also found that risk of acquiring MeS did not have a notable
impact on the level of pain perceived by patients with OA.
In this study, we employed the K&L method to diagnose and
differentiate between case and control groups, so the participants
who entered the control group had no OA related complication.
Perhaps the meaningful difference between the case and control
groups found in our study was due to this matter. Nonetheless, our
study had some limitations. The cross-sectional nature of the study
did not allow us to examine causality or eliminate reverse
causation relationships. Despite great efforts to reduce confound-
ing factors, due to the observational nature of the study these
factors still exist. We only examined the knee joint and as studies
have indicated, there may be difference in different joints
regarding their association with metabolic factors. However, we
did adjust for BMI to eliminate this difference. Although we did not
separate ethnic groups, our study included different ethnic groups
including Turk, Farsi and Arab, which is among the strong point of
our study. Lifestyle differences and different socio-economic status
between these ethnic groups are factors which cannot be resolved.
In conclusion, our ﬁndings revealed that metabolic markers are
strongly associated with OA, therefore control of metabolic factors
and appropriate screening must be considered in health policy
making and prevention programs, especially in Iran where the
rates of MeS are high compared to other countries [12]. More
speciﬁcally, special attention should be given to abdominal obesity
(WC) and hyperlipidemia. Excess fat in the abdominal area can
have an impact on OA, which is independent from the general
obesity measured using BMI.
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